Former FDA Commissioner Andrew Von Eschenbach Joins Another Board–Banyan Biomarkers
Posted May 16 2012 3:10am
Banyan Biomarkers provides analytical services to pharmaceutical companies, biotechnology companies and investigators at academic research institutes. The company has a focus on traumatic brain injury and developing assays to qualify biomarkers. BD
ALACHUA, Fla.--( BUSINESS WIRE )--Banyan Biomarkers, Inc. today announced that Andrew von Eschenbach, MD, former Commissioner of the Food and Drug Administration (FDA) and former Director of the National Cancer Institute (NCI), was elected to its Board of Directors.